The FDA already approved the PFS for nAMD, DME and RVO in July 2024. Vabysmo’s Growth Fuels RHHBY The drug’s stellar ...

Roche’s Genentech unit has said will reintroduce its Susvimo ... and Roche’s new drug Vabysmo (faricimab), currently require injections every month, at least initially. Thereafter, dosing ...

A study has shown that Roche's diabetic macular oedema (DME) therapy Vabysmo is effective in patients who identify as African American, Black, Hispanic and Latino, plugging a gap in the data for ...